Dentistry
Teeth-whitening challenge gets high court review
The Supreme Court will examine the North Carolina dental regulatory board's claim that only dentists should be allowed to whiten teeth.
Mar 3, 2014
0
0
Page 14 - News tagged with competition
Medications
Actavis to buy Forest Labs in $25 billion deal (Update 3)
Irish drugmaker Actavis PLC plans to buy Forest Laboratories Inc. for about $25 billion, catapulting little-known Actavis into the world's No. 15 drug company, with an unusual one-stop-shopping model giving it an edge: more ...
Feb 18, 2014
0
0
Other
Novartis Q4 net profit rises to $2.0 billion
Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.
Jan 29, 2014
0
0
Other
Pfizer's 4Q net plunges on charges, sales decline
Drugmaker Pfizer said Tuesday that fourth-quarter profit plunged 59 percent because of discontinued operations, restructuring and other charges, and generic competition continuing to siphon off revenue from former blockbuster ...
Jan 28, 2014
0
0
Other
Pfizer 3Q net falls due to generics, higher costs
Pfizer Inc.'s third-quarter profit dropped 19 percent as competition from generic drugs continued to cut sales, while lower operating expenses failed to offset higher taxes and charges.
Oct 29, 2013
0
0
Other
Merck 3Q net income falls on charges, lower sales
Merck & Co. said Monday that its third-quarter profit plunged 35 percent because of competition from generic drugs, lower sales of its top-selling medicine, and restructuring and acquisition charges. It still beat Wall Street's ...
Oct 28, 2013
0
0
Health
Studies take early look at health law's premiums
Coverage under President Barack Obama's health care law won't be cheap, but two independent private studies show that cost-conscious consumers hunting for lower premiums will have plenty of options.
Sep 4, 2013
0
0
Other
AstraZeneca to pay about $260M for Omthera Pharma (Update 2)
British drugmaker AstraZeneca PLC plans to spend about $260 million on Omthera Pharmaceuticals Inc., a specialty drug developer with only 14 employees but has a potential treatment for patients who have high levels of fats ...
May 28, 2013
0
0
Other
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Medications
US Justice Department appeals morning-after case
(AP)—The Obama administration appealed a federal judge's order to lift all age limits on who can buy morning-after birth control pills without a prescription. In appealing the ruling on Wednesday, the administration recommitted ...
May 2, 2013
0
0
